US Patent Issued to PHARMACT HOLDING on June 23 for "Modified bacterial hyaluronidase polypeptide, production process, pharmaceutical compositions and their uses" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,664, issued on June 23, was assigned to PHARMACT HOLDING AG (Baar, Switzerland).

"Modified bacterial hyaluronidase polypeptide, production process, pharmaceutical compositions and their uses" was invented by Gunther Burgard (Homburg, Germany), Rainer Boehnke (Berlin), Sven Benson (Stuttgart, Germany), Lenz Lorenz (Sindelfingen, Germany) and Philipp Schellenberger (Remshalden, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a modified bacterial hyaluronidase polypeptide, a production process thereof, and a pharmaceutical composition containing the modified bacterial hyaluronidase polypeptide, and its uses."

The patent was filed o...